11
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Hyperprolactinemia in Systemic Lupus Erythematosus?

, , , , &
Pages 97-102 | Received 16 Aug 1995, Accepted 15 Dec 1995, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Antoni Hrycek, Grażyna Pochopień-Kenig & Joanna Ścieszka. (2007) Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity 40:3, pages 217-222.
Read now

Articles from other publishers (31)

Hend Mehawed Soliman, Balsam Sherif Fahmy, Moataz Gamal Ali & Eman Shafik Shafie. (2023) Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study. Pediatric Rheumatology 21:1.
Crossref
Jinan Q. Mohammed, Abdulsatar Jabar Mathkhor & Zahraa Mustafa Kamel. (2023) Serum Prolactin Level in Women with Systemic Lupus Erythematosus and its Correlation with Disease Activity. Clinical Dermatology Review 7:4, pages 358-362.
Crossref
G G Song & Y H Lee. (2017) Circulating prolactin level in systemic lupus erythematosus and its correlation with disease activity: a meta-analysis. Lupus 26:12, pages 1260-1268.
Crossref
Robert G. Lahita. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 405 423 .
Sara E. Walker. 2010. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine 597 614 .
Mohammadhassan JOKAR, Naser TAYYEBI MAYBODI, Azam AMINI & Mohammadreza HATEF FARD. (2008) Prolactin and macroprolactin in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases 11:3, pages 257-262.
Crossref
K. CHAVEZ-RUEDA, V. MA. LEGORRETA-HAQUET, H. CERVERA-CASTILLO, L. SANCHEZ, L. J. JARA, E. ZENTENO, L. CHAVEZ-SANCHEZ & F. BLANCO-FAVELA. (2007) Effect of Prolactin on Lymphocyte Activation from Systemic Lupus Erythematosus Patients. Annals of the New York Academy of Sciences 1108:1, pages 157-165.
Crossref
Anousheh HAGHIGHI & Farhad LAHMI. (2006) Hyperprolactinemia in patients with systemic lupus erythematosus: correlation with disease activity. APLAR Journal of Rheumatology 9:3, pages 227-231.
Crossref
ROBERT G. LAHITA. 2006. The Autoimmune Diseases. The Autoimmune Diseases 317 328 .
Abdellah El Maghraoui, Saida Tellal, Souad Chaouir, Khalil Lebbar, Ahmed Bezza, Abderrazak Nouijai, Lahsen Achemlal, Sanaa Bouhssain & El Mostapha Derouiche. (2004) Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis. Clinical Rheumatology 24:4, pages 346-351.
Crossref
Vincent GeenenNele Martens, Elisabeth Hooghe-Peters & Robert Hooghe. 2004. Immunoendocrinology in Health and Disease. Immunoendocrinology in Health and Disease 207 239 .
SARA E. WALKER. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine 1128 1138 .
ROBERT G. LAHITA. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine 1093 1105 .
Robert G. Lahita. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 203 221 .
Robert W. McMurray & Warren May. (2003) Sex hormones and systemic lupus erythematosus: Review and meta-analysis. Arthritis & Rheumatism 48:8, pages 2100-2110.
Crossref
Elena Peeva, Daniel Michael, James Cleary, Jeffrey Rice, Xian Chen & Betty Diamond. (2003) Prolactin modulates the naive B cell repertoire. Journal of Clinical Investigation 111:2, pages 275-283.
Crossref
Elena Peeva, Daniel Michael, James Cleary, Jeffrey Rice, Xian Chen & Betty Diamond. (2003) Prolactin modulates the naive B cell repertoire. Journal of Clinical Investigation 111:2, pages 275-283.
Crossref
Susan M. Richards. 2002. Growth and Lactogenic Hormones. Growth and Lactogenic Hormones 275 286 .
F Blanco-FavelaMa G Quintal, A K Chavez-Rueda, A Leaños-Miranda, R Berron-Peres, V Baca-Ruiz & C Lavalle-Montalvo. (2016) Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients. Lupus 10:11, pages 803-808.
Crossref
L J Jara, O Vera-Lastra, J M Miranda, M Alcala & J Alvarez-Nemegyci. (2016) Prolactin in human systemic lupus erythematosus. Lupus 10:10, pages 748-756.
Crossref
A M Jacobi, W Rohde, M Ventz, G Riemekasten, G-R Burmester & F Hiepe. (2016) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10:8, pages 554-561.
Crossref
Robert W. McMurray. (2001) Bromocriptine in rheumatic and autoimmune diseases. Seminars in Arthritis and Rheumatism 31:1, pages 21-32.
Crossref
A Leaños-Miranda, D Pascoe-Lira, K A Chávez-Rueda & F Blanco-Favela. (2016) Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia. Lupus 10:5, pages 340-345.
Crossref
S E Walker. (2016) Treatment of systemic lupus erythematosus with bromocriptine. Lupus 10:3, pages 197-202.
Crossref
C C Mok & R W S Wong. (2001) Pregnancy in systemic lupus erythematosus. Postgraduate Medical Journal 77:905, pages 157-165.
Crossref
Warrington Richard, Tim Mccarthy, Eva Nagy, Kingsley Lee & Istvan Berczi. 2001. 409 416 .
Elena Peeva, Christine Grimaldi, Linda Spatz & Betty Diamond. (2000) Bromocriptine restores tolerance in estrogen-treated mice. Journal of Clinical Investigation 106:11, pages 1373-1379.
Crossref
Sara E. Walker & Jill D. Jacobson. (2000) ROLES OF PROLACTIN AND GONADOTROPIN-RELEASING HORMONE IN RHEUMATIC DISEASES. Rheumatic Disease Clinics of North America 26:4, pages 713-736.
Crossref
S E Walker, D Miller, D L Hill & G R Komatireddy. (2016) Prolactin, a pituitary hormone that modifies immune responses. Lupus 7:6, pages 371-375.
Crossref
C Ferreira, M Paes, A Gouveia, E Ferreira, F Pádua & T Fiuáza. (2016) Plasma homovanillic acid and prolactin in systemic lupus erythematosus. Lupus 7:6, pages 392-397.
Crossref
A Leaños, D PascoeA FragaF Blanco-Favela. (2016) Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 7:6, pages 398-403.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.